CFTC files charges over fraudulent binary options trading scheme
By 
Jaclyn Jaeger2019-08-13T15:50:00
The CFTC is pursuing enforcement against five entities and four individuals for engaging in a fraudulent scheme to solicit global customers for the purported purpose of trading illegal, off-exchange binary options.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
Blog
CFTC, SEC issue joint enforcement warning on virtual currencies
The CFTC and SEC have issued a warning regarding virtual currencies. They “will look beyond form, examine the substance of the activity, and prosecute violations of the federal securities and commodities laws.”
-
Blog
FCA issues list of unauthorised binary options providers
The U.K. Financial Conduct Authority this month published a list of 94 firms believed to be offering binary options trading to U.K. consumers without FCA authorisation. Since 3 January 2018, all firms trading in binary options need to be authorised by the FCA.
-
ArticleFINRA executive explains regulator's use of AI at Compliance Week event
The Financial Industry Regulatory Authority (FINRA) has welcomed artificial intelligence (AI) with open arms—and also caution.
More from Regulatory Enforcement
-
ArticleFrench investigators target anticompetitive practices in largest accounting firms
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
-
ArticleEU investigation into Grok may expose problems with DSA rather than compliance failings
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
-
ArticleFormer ADM execs inflated operating profits, SEC alleges
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.